Longitudinal fluctuations in PD1 and PD-L1 expression in association with changes in anti-viral immune response in chronic hepatitis B
Zhang Wenjin, Peng Chuanhui, Wan Yunle, Shaikh Abdul Lateef, Zheng Shusen, Zhang Wenjin, Peng Chuanhui, Wan Yunle, Shaikh Abdul Lateef, Zheng Shusen
Abstract
Background: Controversy exists regarding the role of PD1 and its ligand PD-L1 in chronic hepatitis B infection. In some studies, persistent HBV infection has been attributed to high levels of PD-1 and PD-L1 expression on HBV-specific T-cells and antigen-presenting cells (APCs) respectively. Other studies revealed that the up-regulation of PD-1 and PD-L1 during an acute inflammation phase is required to offset increasing positive co-stimulatory signals to avoid severe damage by an over-vigorous immune response.
Methods: Fifteen chronic hepatitis B patients, with inflammatory flare episode, were recruited prospectively. Based on serum HBV-DNA, HBsAg load, and ALT values, inflammatory flare episode were divided into initial, climax, decline and regression phase. Blood sample and liver biopsy tissues from each individual were taken in these 4 phases respectively. Circulating and intra-hepatic PD1 and PD-L1 expression levels were monitored throughout the inflammatory flare episode by flow cytometry and immunostaining and these expression levels were related to the HBV-specific T-cell changes, expression of pro-inflammatory cytokines, HBV-DNA replication and HBV antigen load.
Results: ]The levels of PD-1 and PD-L1 expressions were significantly up-regulated in the inflammation ascending phase, initial and climax period and in parallel with HBV-specific colon expansion. It showed increasing the level of serum ALT and decreasing the HBV-DNA loads. As the level of inflammation reduced, the circulating and intra-hepatic PD1 and circulating PD-L1 decreased progressively in concordance with serum ALT, HBV-DNA and HBsAg loads decreased except intra-hepatic PD-1 expression. Intra-hepatic PD-L1 expression did not decrease significantly during the regression phase of inflammation compared to that in prior period. The intra-hepatic PD-L1 expression remained relatively on higher level when serum HBV-DNA load and ALT decreased to approximately normal range.
Conclusion: The relatively high level of intra-hepatic PD-L1 expression during the inflammatory regression period may contribute to constitute an immunosuppressive microenvironment, which facilitate persistent HBV infection via the inhibition of HBV-specific T cell clonal expansion.
Figures
References
- Peng G, Li S, Wu W. et al.PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol Immunol. 2008;45:963–970. doi: 10.1016/j.molimm.2007.07.038.
- Evans A, Riva A, Cooksley H. et al.Programmed Death 1 Expression During Antiviral Treatment of Chronic Hepatitis B: Impact of Hepatitis B e-Antigen Seroconversion. Hepatology. 2008;48:759–769. doi: 10.1002/hep.22419.
- Rutebemberwa A, Ray SC, Astemborski J. et al.High-Programmed Death-1 Levels on Hepatitis C Virus-Specific T Cells during Acute Infection Are Associated with Viral Persistence and Require Preservation of Cognate Antigen during Chronic Infection1. J Immunol. 2008;181:8215–8225.
- Urbani S, Amadei B, Tola D. et al.PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion. J Virol. 2006;80:11398–11403. doi: 10.1128/JVI.01177-06.
- Jeong H-Y, Lee Y-J, Seo S-K. et al.Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection. J Leukoc Biol. 2008;83:755–764.
- Carolina B, Paola F, Caterina V. Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection. J Virol. 2007;81:4215–4225. doi: 10.1128/JVI.02844-06.
- Victoria K, Wiesch JSz, Thomas K. et al.High Level of PD-1 Expression on Hepatitis C Virus (HCV)-Specifi CD8+ and CD4+ T Cells during Acute HCV Infection, Irrespective of Clinical Outcome. J Virol. 2008;82:3154–3160. doi: 10.1128/JVI.02474-07.
- Lucy G-M, Brent P, Jared K. et al.Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune Dysfunction. J Virol. 2007;81:9249–9258. doi: 10.1128/JVI.00409-07.
- Selenko-Gebauer N, Majdic O, Szekeres A. et al.B7-H1 (Programmed Death-1 Ligand) on Dendritic Cells Is Involved in the Induction and Maintenance of T Cell Anergy. J Immunol. 2003;170:3637–3644.
- Iwai Y, Terawaki S, Ikegawa M. et al.PD-1 Inhibits Antiviral Immunity at the Effector Phase in the Liver. J. Exp. Med. 2003;198:39–50. doi: 10.1084/jem.20022235.
- Karrar A, Broome U, Uzunel M. et al.Human liver sinusoidal endothelial cells induce apoptosis in activated T cells: a role in tolerance induction. Gut. 2007;56:243–252. doi: 10.1136/gut.2006.093906.
- Chen L, Zhang Z, Chen W. et al.B7–H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. J Immunol. 2007;178:6634–6641.
- Yu MC, Chen CH, Liang X. et al.Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology. 2005;40:1312–1321.
- Kassel R, Cruise MW, Iezzoni JC. et al.Chronically inflamed livers up-regulate expression of inhibitory B7 family members. Hepatology. 2009;50(5):1625–1637. doi: 10.1002/hep.23173.
- Poly M. Tolerance, danger, and the extended family. Annu. Rev.lmmunol. 1994;12:991–1045. doi: 10.1146/annurev.iy.12.040194.005015.
- By Hiroyuki Y, Kenjiro M, Yanyun Z. et al.Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract–associated lymphoid tissue, in a granulomatous liver disease. J. Exp. Med. 2001;193:35–49. doi: 10.1084/jem.193.10.F35.
- Hiroyuki Y, Kenjiro M, Yanyun Z. et al.Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract–associated lymphoid tissue, in a granulomatous liver disease. J. Exp. Med. 2001;193:35–49. doi: 10.1084/jem.193.10.F35.
- Grant AJ, Goddard S, Ahmed-Choudhury J. et al.Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol. 2002;160:1445–1455. doi: 10.1016/S0002-9440(10)62570-9.
- Mazanet MM, Hughes CC. et al.B7–H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J Immunol. 2002;169:3581–3588.
- Rodig N, Ryan T, Allen J. A., Greenfield, E A, et al.: Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol. 2003;33:3117–3126. doi: 10.1002/eji.200324270.
- Muhlbauer M, M Fleck C, Schutz T. et al.PD-L1 is induced in hepatocytes by viral infection and by interferon-α andγand mediates T cell apoptosis. J Hepatol. 2006;45:520–528. doi: 10.1016/j.jhep.2006.05.007.
- Abhishek D, Matthew H, Nathan D. et al.Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med. 2008;205(9):2111–2124. doi: 10.1084/jem.20072076.
Source: PubMed